A detailed history of Gts Securities LLC transactions in Kempharm, Inc stock. As of the latest transaction made, Gts Securities LLC holds 61,600 shares of KMPH stock, worth $304,304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,600
Previous 31,740 94.08%
Holding current value
$304,304
Previous $156,000 94.87%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
N/A
-7,637 Reduced 24.06%
24,103 $119,000
Q2 2024

Aug 14, 2024

BUY
N/A
17,621 Added 124.8%
31,740 $156,000
Q1 2024

May 15, 2024

BUY
N/A
14,119 New
14,119 $69,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.